247 related articles for article (PubMed ID: 22748800)
21. Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells.
Tartey S; Takeuchi O
Int Rev Immunol; 2017 Mar; 36(2):57-73. PubMed ID: 28060562
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines.
Kuznik A; Bencina M; Svajger U; Jeras M; Rozman B; Jerala R
J Immunol; 2011 Apr; 186(8):4794-804. PubMed ID: 21398612
[TBL] [Abstract][Full Text] [Related]
23. Toll-like receptors in inflammation of the central nervous system.
Kong Y; Le Y
Int Immunopharmacol; 2011 Oct; 11(10):1407-14. PubMed ID: 21600311
[TBL] [Abstract][Full Text] [Related]
24. Role of Toll-like receptors in liver health and disease.
Broering R; Lu M; Schlaak JF
Clin Sci (Lond); 2011 Nov; 121(10):415-26. PubMed ID: 21797822
[TBL] [Abstract][Full Text] [Related]
25. Toll-like receptors, inflammation and cancer.
Tsan MF
Semin Cancer Biol; 2006 Feb; 16(1):32-7. PubMed ID: 16153858
[TBL] [Abstract][Full Text] [Related]
26. Toll-like receptors as therapeutic targets for cancer.
Holldack J
Drug Discov Today; 2014 Apr; 19(4):379-82. PubMed ID: 24012797
[TBL] [Abstract][Full Text] [Related]
27. Modulation of toll-like receptor function has therapeutic potential in autoimmune disease.
Clanchy FI; Sacre SM
Expert Opin Biol Ther; 2010 Dec; 10(12):1703-16. PubMed ID: 21039312
[TBL] [Abstract][Full Text] [Related]
28. [Responses with participation of toll-like receptors in protective immunity and in pathologic states].
Skivka LM; Pozur VV
Ukr Biokhim Zh (1999); 2008; 80(3):5-20. PubMed ID: 18959023
[TBL] [Abstract][Full Text] [Related]
29. Toll-like receptors in ocular surface diseases: overview and new findings.
Lambiase A; Micera A; Sacchetti M; Mantelli F; Bonini S
Clin Sci (Lond); 2011 May; 120(10):441-50. PubMed ID: 21271987
[TBL] [Abstract][Full Text] [Related]
30. The role of toll-like receptors in host defenses and their relevance to dermatologic diseases.
Terhorst D; Kalali BN; Ollert M; Ring J; Mempel M
Am J Clin Dermatol; 2010; 11(1):1-10. PubMed ID: 20000870
[TBL] [Abstract][Full Text] [Related]
31. Toll-like receptors and chronic inflammation in rheumatic diseases: new developments.
Joosten LA; Abdollahi-Roodsaz S; Dinarello CA; O'Neill L; Netea MG
Nat Rev Rheumatol; 2016 Jun; 12(6):344-57. PubMed ID: 27170508
[TBL] [Abstract][Full Text] [Related]
32. Modulation of toll-like receptors by insulin.
Tilich M; Arora RR
Am J Ther; 2011 Sep; 18(5):e130-7. PubMed ID: 21326087
[TBL] [Abstract][Full Text] [Related]
33. Drugs targeting Toll-like receptors.
Krishnan J; Lee G; Choi S
Arch Pharm Res; 2009 Nov; 32(11):1485-502. PubMed ID: 20091261
[TBL] [Abstract][Full Text] [Related]
34. [Expression and function of toll-like receptors in B lymphocytes].
Liu HZ; Yang HZ; Hu ZW
Sheng Li Ke Xue Jin Zhan; 2008 Apr; 39(2):114-8. PubMed ID: 18664173
[TBL] [Abstract][Full Text] [Related]
35. Dual role of Toll-like receptors in asthma and chronic obstructive pulmonary disease.
Bezemer GF; Sagar S; van Bergenhenegouwen J; Georgiou NA; Garssen J; Kraneveld AD; Folkerts G
Pharmacol Rev; 2012 Apr; 64(2):337-58. PubMed ID: 22407613
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptors in rheumatic diseases: are we paying a high price for our defense against bugs?
Santegoets KC; van Bon L; van den Berg WB; Wenink MH; Radstake TR
FEBS Lett; 2011 Dec; 585(23):3660-6. PubMed ID: 21513712
[TBL] [Abstract][Full Text] [Related]
37. Toll-like receptor signaling pathways and the evidence linking toll-like receptor signaling to cardiac ischemia/reperfusion injury.
Wang Y; Abarbanell AM; Herrmann JL; Weil BR; Poynter J; Manukyan MC; Crisostomo PR; Meldrum DR
Shock; 2010 Dec; 34(6):548-57. PubMed ID: 20458266
[TBL] [Abstract][Full Text] [Related]
38. Toll-like receptors and genital tract infection.
Sonnex C
Int J STD AIDS; 2010 Mar; 21(3):153-7. PubMed ID: 20215617
[TBL] [Abstract][Full Text] [Related]
39. Viral recognition by Toll-like receptors.
Barton GM
Semin Immunol; 2007 Feb; 19(1):33-40. PubMed ID: 17336545
[TBL] [Abstract][Full Text] [Related]
40. Toll-like receptor signalling and the clinical benefits that lie within.
Verstak B; Hertzog P; Mansell A
Inflamm Res; 2007 Jan; 56(1):1-10. PubMed ID: 17334664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
